The Israeli Diamond Industry Portal
News Center
News
Israel
World
Mining
Retail
Press Releases
IDI takes China by storm
2008 - Turning to India
Liberian Memorandum of Understanding
Rough Conference
Financial News
Newsletter
Features
Video Clips
Photo Galleries
Become a Member
Sign up and enjoy the benefits
Get Our Newsletter
IDEX Online Prices
IDEX Online Index
Currency Rates | Conversion Calculator
Update Date : 05.02.10
Currency Rate %
US Dollar 3.747 0.672
Euro 5.131 -0.44
GBP 5.879 -0.35
100 JPY 4.177 1.798
CNY 0.548 0.166
HKD 0.482 0.188
World Clock
Hong Kong  23:09
New York  10:09
Mumbai  20:39
Jerusalem  17:09
Brussels  16:09
Moscow  18:09
Diamond Needs | Supply | Blog | Diamond Companies | About Israel | Wikidiamond |
diamond trade diamonds diamond companies diamond manufacture diamond center buying diamonds
News Center > News > Financial News

Diamond News

Compugen Signs Collaboration Agreements with Two Leading Pharmaceutical Companies

Israeli drug company to partner with Roche Holdings and Merck & Co
26.03.08, 10:06 / Financial News

Swiss healthcare company, Roche Holdings AG, and Israeli Compugen Ltd have signed a collaboration agreement to utilize Compugen's proprietary GeneVa platform to analyze DNA samples and clinical data provided by Roche for the study and treatment of Rheumatoid Arthritis (RA). RA, a common autoimmune disease that causes chronic inflammation of the joints, affects more than 21 million people worldwide.

 

Compugen has also entered into an agreement with US Merck & Co to predict and validate peptides that are likely to activate G-protein coupled receptors (GPCRs), the largest family of known drug targets, on which at least 40% of all prescription drugs currently available are thought to act on. Merck is to use Compugen's GPCR discovery engine in its drug development programs. Roche Holdings AG, based in Switzerland, is one of the leading global healthcare companies in the world, with total 2007 revenues of over $46 billion. Merck & Co is a global research-driven pharmaceutical company with 2007 revenues of $24.2 billion. Compugen Ltd. located in Tel Aviv, is a biotechnology discovery company focused on therapeutic and diagnostic products.

 

Source: Invest in Israel

 

 

 

 

| | | | | | התראות RSS

 
Sign Up For Our Newsletter

more news   |  more financial news news
News Rss Feeds
RETAIL
AGTA GemFair reveals leading buyer trends
09.02.10, 11:25
RETAIL
EBay announces 'Build Your Bling' diamond ring contest
09.02.10, 10:52
WORLD
De Beers opens Diamond Route in South Africa
09.02.10, 10:26
WORLD
Botswana Expects Economy to Rebound on Diamonds
09.02.10, 10:09
WORLD
Suspect arrested in Campbell Bridges murder case
09.02.10, 10:01
Financial News
Israeli Consumer Confidence Index up in January
09.02.10, 10:34
Common Searches
diamond price
buying diamonds
Israel diamond exchange
Diamond Needs
Round,0.18 - 0.23
(28.12.09)
Round,0.23 - 0.40
(28.12.09)
This week's most popular news
Rio Tinto's diamond chief heads to Zimbabwe
2 new super-hard diamonds found in meteorite
Rio Tinto close to ruling on restarting Argyle diamond mine
IDI – מכון היהלומים הישראלי ewave